Taurine supplemented cell culture medium and methods of use
US-12577528-B2 · Mar 17, 2026 · US
This page is not indexed by search engines while we improve data quality.
Casey Meghan E patents
Casey Meghan E is listed as an inventor on 15 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Casey Meghan E |
| Total patents | 15 |
| First publication | Aug 9, 2018 |
| Latest publication | Mar 17, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Taurine supplemented cell culture medium and methods of use
US-2025340832-A1 · Nov 6, 2025 · US
Taurine supplemented cell culture medium and methods of use
US-2025327023-A1 · Oct 23, 2025 · US
Taurine supplemented cell culture medium and methods of use
US-12359165-B2 · Jul 15, 2025 · US
Taurine supplemented cell culture medium and methods of use
US-12359166-B2 · Jul 15, 2025 · US
Taurine supplemented cell culture medium and methods of use
US-12221619-B2 · Feb 11, 2025 · US
Taurine supplemented cell culture medium and methods of use
US-2024309316-A1 · Sep 19, 2024 · US
Taurine supplemented cell culture medium and methods of use
US-2024309315-A1 · Sep 19, 2024 · US
Taurine supplemented cell culture medium and methods of use
US-2024018467-A1 · Jan 18, 2024 · US
Anti-VEGF protein compositions and methods for producing the same
US-11753459-B2 · Sep 12, 2023 · US
Recent patents
Latest publications not already listed above.
Taurine supplemented cell culture medium and methods of use
US-2022235318-A1 · Jul 28, 2022 · US
Taurine supplemented cell culture medium and methods of use
US-11312936-B2 · Apr 26, 2022 · US
Taurine supplemented cell culture medium and methods of use
US-10927342-B2 · Feb 23, 2021 · US
Taurine supplemented cell culture medium and methods of use
US-2020157492-A1 · May 21, 2020 · US
Taurine supplemented cell culture medium and methods of use
US-2018223249-A1 · Aug 9, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Regeneron Pharma | 15 |
| Regeneran Pharmaceuticals Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N15/85 | 15 |
| C12N2510/02 | 15 |
| C12N2500/32 | 15 |
| C12N5/0018 | 15 |
| C12P21/00 | 14 |